Results 161 to 170 of about 208,282 (274)

Bayesian geostatistical modeling of leishmaniasis incidence in Brazil.

PLoS Neglected Tropical Diseases, 2013
BackgroundLeishmaniasis is endemic in 98 countries with an estimated 350 million people at risk and approximately 2 million cases annually. Brazil is one of the most severely affected countries.MethodologyWe applied Bayesian geostatistical negative ...
Dimitrios-Alexios Karagiannis-Voules, Ronaldo G C Scholte, Luiz H Guimarães, Jürg Utzinger, Penelope Vounatsou   +4 more
doaj   +1 more source

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. [PDF]

, 2000
OBJECTIVE: To compare the outcome of treatment of Sudanese kala-azar patients treated under field conditions with either branded sodium stibogluconate (SSG) (Pentostam GlaxoWellcome) or generic SSG (Albert David Ltd, Calcutta, supplied by International ...
Davidson, R N, Ritmeijer, K, Seaman, J, Veeken, H   +3 more
core   +2 more sources

Visceral leishmaniasis in lung transplantation

Transplantation Proceedings, 2003
Infection by intracellular microorganisms with a special geographic distribution, such as Leishmania spp, has been reported in a limited number of patients undergoing solid-organ transplant (SOT). No cases of Leishmania spp infection in lung transplant patients were found in a review of the literature.
P. Morales, Amparo Solé, J Lacruz, Javier Pemán, M Salavert, J.J Torres   +5 more
openaire   +3 more sources

A current perspective on leishmaniasis

Journal of Global Infectious Diseases, 2010
There are many challenges facing the successful control and eradication of cutaneous and visceral leishmaniasis. Leishmaniasis is still endemic in many poverty stricken and war torn areas.
Angela Clem
doaj   +1 more source

Management of trypanosomiasis and leishmaniasis [PDF]

, 2012
<p>Background: The current treatments for human African trypanosomiasis (HAT), Chagas disease and leishmaniasis (collectively referred to as the kinetoplastid diseases) are far from ideal but, for some, there has been significant recent progress ...
Alsford, Alvar, Alvar, Barrett, Barrett, Ben Salah, Berman, Bern, Brun, Brun, Burri, Chappuis, Coura, Croft, Croft, El-Sayed, Frearson, Hailu, Jacobs, Jacobs, Le Loup, Lessa, M. P. Barrett, Miranda-Verastegui, Paine, Pinazo, Priotto, Rassi, Reithinger, Rodgers, S. L. Croft, Stuart, Sundar, Sundar, Sundar, Sundar, Torreele, Vanhollebeke, Vincent, Voogd   +39 more
core   +2 more sources

Recent autochthonous cases of leishmaniasis in residents of the Republic of Dagestan, Russian Federation

International Journal of Infectious Diseases, 2019
Eighty years after the last published record of human leishmaniasis from Dagestan, Russian Federation, we report two recent cases which were most probably acquired locally: one case of visceral leishmaniasis in a 2-year old child, and one cutaneous ...
Sergey Andreevich Nagorny, Larisa Alexandrovna Ermakova, Natalia Vladimirovna Golovchenko, Natalia Yurievna Pshenichnaya, Andrey Sergeevich Zhuravlev, Trentina Di Muccio, Luigi Gradoni   +6 more
doaj  

Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study

Infection and Drug Resistance, 2020
Brhane Tesfanchal,1 Gebremedhin Gebremichail,2 Getachew Belay,1 Gebreslassie Gebremariam,3 Gebreyohannes Teklehaimanot,4 Hagos Haileslasie,2 Getachew Kahsu,1 Aderajew Gebrewahd,5 Fitsum Mardu,6 Gebre Adhanom,5 Brhane Berhe,6 Hirut Teame,7 Aster Tsegaye,8
Tesfanchal B, Gebremichail G, Belay G, Gebremariam G, Teklehaimanot G, Haileslasie H, Kahsu G, Gebrewahd A, Mardu F, Adhanom G, Berhe B, Teame H, Tsegaye A, Wolde M   +13 more
doaj  

Developments in the treatment of visceral leishmaniasis

Expert Opinion on Emerging Drugs, 2009
Visceral leishmaniasis (VL) is one of the most neglected parasitic diseases causing large scale mortality and morbidity among the poorest of the poor in the Indian subcontinent and Africa.This review aims to describe the potential and the (lack of) current impact of newly developed treatments on the control of VL.
Koert Ritmeijer, Jorge Alvar, Manica Balasegaram, Margriet den Boer, Robert N. Davidson   +4 more
openaire   +4 more sources

Evaluation of a New Recombinant K39 Rapid Diagnostic Test for Sudanese Visceral Leishmaniasis. [PDF]

, 2006
A new rK39 rapid diagnostic dipstick test (DiaMed-IT-Leish) was compared with aspiration and a direct agglutination test (DAT) for diagnosis of visceral leishmaniasis (VL) in 201 parasitologically confirmed cases, 133 endemic controls, and in 356 ...
Davidson, R N, Kipngetich, S, Melaku, Y, Mueller, M, O'keeffe, C, Ritmeijer, K   +5 more
core   +1 more source

Environmental change increases the transmission risk of visceral leishmaniasis in central China around the Taihang mountains

Environmental Health
Background Visceral leishmaniasis is a neglected life-threatening sandfly-borne disease, which brings a growing public health threat in Central China around the Taihang Mountains.
Ze Meng, Pei-Wei Fan, Zi-Xuan Fan, Shuai Chen, Hou Jiang, Yue Shi, Ling Yao, Jian-Yi Yao, Ye-Ping Wang, Meng-Meng Hao, Wen-Qi Xie, Yong-Qing Bai, Qian Wang, Kai Sun, Xiao-Lan Xie, Jian-Wei Zhou, Dong Jiang, Can-Jun Zheng, Hua Wu, Tian Ma, Fang-Yu Ding   +20 more
doaj   +1 more source